<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00014859</url>
  </required_header>
  <id_info>
    <org_study_id>967</org_study_id>
    <nct_id>NCT00014859</nct_id>
    <nct_alias>NCT00200915</nct_alias>
  </id_info>
  <brief_title>Epidemiology of Surfactant Protein-B Deficiency</brief_title>
  <official_title>Epidemiology of Surfactant Protein-B Deficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test the hypothesis that excess, rare, functionally
      disruptive single nucleotide polymorphisms (SNPs) characterize genes (e.g., the surfactant
      protein-B gene)(SFTPB) and gene networks (e.g., the pulmonary surfactant metabolic network)
      associated with increased risk of neonatal respiratory distress syndrome (RDS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:

      Respiratory distress syndrome is the most frequent respiratory cause of death and morbidity
      in infants less than 1 year of age in the United States. Of approximately 28,500 infant
      deaths in 2006, 5,421 (19.7%) were diagnosed with respiratory distress as either the primary
      (1,011 - 3.7%) or secondary (4,410 - 16%) cause of death. Despite improvement in infant
      mortality rates over the last 20 years, survivors of respiratory distress syndrome with
      chronic respiratory disease consume twenty times more annualized dollars than unaffected
      children and 5.9% of all dollars spent on children from 0-18 years of age. More recent
      estimates including data from California and New York, the Institute of Medicine, and the
      2001 Nationwide Inpatient Sample from the Healthcare Cost and Utilization Project suggest
      that the average cost of hospitalization for each of the 49,900 infants with a diagnosis of
      respiratory distress syndrome was $56,800 vs. $10,700 for a premature infant without
      respiratory distress syndrome. The recent increase in late preterm births has contributed to
      both the frequency of respiratory distress syndrome and its economic impact. These medical
      costs do not include the economic consequences of infant respiratory morbidity for families,
      e.g., absence from work, and early intervention costs to optimize outcome. In addition,
      despite 2-3 fold greater risk of infant mortality for African American infants than European
      American infants from all other causes, European American infants have greater risk of death
      from respiratory distress than African American infants, and this increased risk is not
      attributable to differences in surfactant phospholipid composition, birth weight, gestational
      age, or confounding socioeconomic factors. Understanding the genetic mechanisms that cause
      respiratory distress syndrome is critical for improving outcomes of children in the United
      States, reducing costs of their health care, and reducing racial disparity in infant
      mortality. Since the original description of deficiency of the pulmonary surfactant in
      premature newborn infants by Avery and Mead in 1959, respiratory distress syndrome has most
      commonly been attributed to developmental immaturity of pulmonary surfactant production.
      Despite improvement in neonatal survival associated with availability of surfactant
      replacement therapy for premature infants, gender and race based disparities in disease
      frequency, morbidity and mortality have persisted, an observation that suggests that genetic
      factors play an important role in disease pathogenesis. In addition, twin studies indicate
      high heritability (h2) of neonatal respiratory distress syndrome (0.2 and 0.8). Recent
      clinical reports of monogenic causes of neonatal respiratory distress syndrome, statistical
      association of candidate gene variants with increased disease risk, and studies of targeted
      gene ablation in murine lineages have also strongly suggested that genetic mechanisms
      contribute to risk of respiratory distress syndrome in newborn infants. When we examined
      genetic variants in large population-based and case-control cohorts, we found that the
      population-based frequencies of individual, disruptive mutations in 3 candidate genes (SFTPB,
      SFTPC, and ABCA3) (&lt;2%) account for &lt;0.1% of the population attributable risk in term or near
      term infants, and that individual, rare, disruptive mutations are not associated with disease
      in case-control cohorts. In addition, when we attempted to establish an association between
      an intermediate biochemical phenotype (surfactant protein-B peptide mobility on western blot)
      and SFTPB variants (assessed by complete resequencing) in term and near term infants with and
      without respiratory distress, we failed to identify a SFTPB variant or combination of
      variants associated with respiratory distress and altered surfactant protein-B structure.
      Finally, we have recently found that tagSNPs in genes from gene networks expressed in lung
      but not part of the pulmonary surfactant network (ion channel, lung remodeling, and unfolded
      protein response genes) confer race-specific risk of neonatal respiratory distress syndrome.
      These studies suggest that variation in SFTPB, SFTPC, and ABCA3 is under significant
      purifying selection pressure and that the genetic contribution to neonatal respiratory
      distress syndrome is based on contributions of rare, independent risk alleles in multiple
      genes and gene networks.

      DESIGN NARRATIVE:

      Rare mutations in the surfactant protein-B gene (SFTPB) and other genes in the pulmonary
      surfactant metabolic network cause lethal neonatal respiratory distress syndrome in human
      newborn infants by disrupting metabolism and function of the pulmonary surfactant. Mutation
      frequencies (&lt;1-2%) in SFTPB and 2 other candidate genes in the pulmonary surfactant network
      (SFTPC and ABCA3) do not account for heritability of neonatal respiratory distress syndrome
      (h2~0.2-0.8) suggested by twin studies. To develop a comprehensive catalogue of genes and
      gene networks that account for the heritability of this complex disease, we propose to test
      the hypothesis that excess, rare, functionally disruptive single nucleotide polymorphisms
      (SNPs) characterize genes and gene networks associated with increased risk of neonatal
      respiratory distress syndrome. Specifically, using trio whole exome or whole genome
      sequencing of affected infant (progressive, severe respiratory distress in term or near term
      infants or children with unexplained interstitial lung disease or other rare lung
      phenotypes)/parent trios, we will identify de novo or recessively inherited pathogenic
      variants including single nucleotide variants, small insertions/deletions, and copy number or
      structural variants (&gt;100 kb). To predict pathogenicity, we will use a suite of computational
      prediction algorithms (e.g., ANNOVAR, CADD). To confirm variants in genes and gene pathways
      not previously associated with human infant/child rare respiratory phenotypes, we will use
      GeneMatcher to identify other affected infants with pathogenic variants at the same gene
      locus or in the same gene pathway or functional testing of identified variants in a variety
      of cell-based jor model organism models. Using next-generation sequencing technology and
      state of the art statistical methods to elucidate the genetic complexity of neonatal
      respiratory distress syndrome and rare infant lung phenotypes will permit the development of
      personalized diagnostic tools and preventive therapeutic strategies for high risk infants and
      young children.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 2001</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>4 Weeks</target_duration>
  <primary_outcome>
    <measure>Statistical association of rare, functionally disruptive genomic variant with RDS</measure>
    <time_frame>4 weeks</time_frame>
    <description>Using custom exon capture, next generation sequencing, and in silico prediction of function, discover statistical associations between gene loci with excess, rare, functionally disruptive variants and risk of neonatal respiratory distress syndrome.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Statistical associations between risk of neonatal respiratory distress syndrome and excess, rare functional variants in gene pathways</measure>
    <time_frame>4 weeks</time_frame>
    <description>Using custom exon capture, next generation sequencing, in silico prediction of functional variants, and Metacore for pathway construction, identify statistical associations between risk of neonatal respiratory distress syndrome and pathways with excess, rare functional variants</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Lung Diseases</condition>
  <condition>Respiratory Distress Syndrome, Newborn</condition>
  <condition>Pulmonary Surfactant</condition>
  <arm_group>
    <arm_group_label>Population-based cohort</arm_group_label>
    <description>Descriptive cohort of population-based DNA samples from the newborn screening program in Missouri with vital statistics based, linked phenotype data</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trio sequencing cohort</arm_group_label>
    <description>Affected infant/child (term or near term infant with progressive respiratory distress or other rare pulmonary phenotype or older child with interstitial lung disease or other rare pulmonary phenotype) and parents</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA and tracheal aspirate samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort I is a population-based cohort from Missouri. Cohort II is a cohort of family trios
        (affected infant/child and parents) which may also include other unaffected or affected
        siblings from the Neonatal Intensive Care Unit at St. Louis Children's Hospital and from
        patients referred from other centers.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal pulmonary function or a diagnosis of RDS

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Year</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>F. Sessions Cole, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>F. Sessions Cole, MD</last_name>
      <phone>314-454-6148</phone>
      <email>cole@kids.wustl.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Merchak A, Janssen DJ, Bohlin K, Patterson BW, Zimmermann LJ, Carnielli VP, Hamvas A. Endogenous pulmonary surfactant metabolism is not affected by mode of ventilation in premature infants with respiratory distress syndrome. J Pediatr. 2002 Jun;140(6):693-8.</citation>
    <PMID>12072872</PMID>
  </reference>
  <reference>
    <citation>Nogee LM. Genetic mechanisms of surfactant deficiency. Biol Neonate. 2004;85(4):314-8. Epub 2004 Jun 8. Review.</citation>
    <PMID>15218289</PMID>
  </reference>
  <reference>
    <citation>Cameron HS, Somaschini M, Carrera P, Hamvas A, Whitsett JA, Wert SE, Deutsch G, Nogee LM. A common mutation in the surfactant protein C gene associated with lung disease. J Pediatr. 2005 Mar;146(3):370-5.</citation>
    <PMID>15756222</PMID>
  </reference>
  <results_reference>
    <citation>Nogee LM. Abnormal expression of surfactant protein C and lung disease. Am J Respir Cell Mol Biol. 2002 Jun;26(6):641-4.</citation>
    <PMID>12034561</PMID>
  </results_reference>
  <results_reference>
    <citation>Cole FS. Surfactant protein B: unambiguously necessary for adult pulmonary function. Am J Physiol Lung Cell Mol Physiol. 2003 Sep;285(3):L540-2. Review.</citation>
    <PMID>12902317</PMID>
  </results_reference>
  <results_reference>
    <citation>Hamvas A, Madden KK, Nogee LM, Trusgnich MA, Wegner DJ, Heins HB, Cole FS. Informed consent for genetic research. Arch Pediatr Adolesc Med. 2004 Jun;158(6):551-5.</citation>
    <PMID>15184218</PMID>
  </results_reference>
  <results_reference>
    <citation>Hamvas A, Nogee LM, White FV, Schuler P, Hackett BP, Huddleston CB, Mendeloff EN, Hsu FF, Wert SE, Gonzales LW, Beers MF, Ballard PL. Progressive lung disease and surfactant dysfunction with a deletion in surfactant protein C gene. Am J Respir Cell Mol Biol. 2004 Jun;30(6):771-6. Epub 2003 Dec 4.</citation>
    <PMID>14656744</PMID>
  </results_reference>
  <results_reference>
    <citation>Hamvas A, Wegner DJ, Trusgnich MA, Madden K, Heins H, Liu Y, Rice T, An P, Watkins-Torry J, Cole FS. Genetic variant characterization in intron 4 of the surfactant protein B gene. Hum Mutat. 2005 Nov;26(5):494-5.</citation>
    <PMID>16211553</PMID>
  </results_reference>
  <results_reference>
    <citation>Palomar LM, Nogee LM, Sweet SC, Huddleston CB, Cole FS, Hamvas A. Long-term outcomes after infant lung transplantation for surfactant protein B deficiency related to other causes of respiratory failure. J Pediatr. 2006 Oct;149(4):548-53.</citation>
    <PMID>17011330</PMID>
  </results_reference>
  <results_reference>
    <citation>Cole FS, Nogee LM, Hamvas A. Defects in surfactant synthesis: clinical implications. Pediatr Clin North Am. 2006 Oct;53(5):911-27, ix. Review.</citation>
    <PMID>17027617</PMID>
  </results_reference>
  <results_reference>
    <citation>Wilson RK, Ley TJ, Cole FS, Milbrandt JD, Clifton S, Fulton L, Fewell G, Minx P, Sun H, McLellan M, Pohl C, Mardis ER. Mutational profiling in the human genome. Cold Spring Harb Symp Quant Biol. 2003;68:23-9. Review.</citation>
    <PMID>15338599</PMID>
  </results_reference>
  <results_reference>
    <citation>Wegner DJ, Hertzberg T, Heins HB, Elmberger G, MacCoss MJ, Carlson CS, Nogee LM, Cole FS, Hamvas A. A major deletion in the surfactant protein-B gene causing lethal respiratory distress. Acta Paediatr. 2007 Apr;96(4):516-20.</citation>
    <PMID>17391469</PMID>
  </results_reference>
  <results_reference>
    <citation>Hamvas A, Wegner DJ, Carlson CS, Bergmann KR, Trusgnich MA, Fulton L, Kasai Y, An P, Mardis ER, Wilson RK, Cole FS. Comprehensive genetic variant discovery in the surfactant protein B gene. Pediatr Res. 2007 Aug;62(2):170-5.</citation>
    <PMID>17597650</PMID>
  </results_reference>
  <results_reference>
    <citation>Saugstad OD, Hansen TW, Rønnestad A, Nakstad B, Tølløfsrud PA, Reinholt F, Hamvas A, Coles FS, Dean M, Wert SE, Whitsett JA, Nogee LM. Novel mutations in the gene encoding ATP binding cassette protein member A3 (ABCA3) resulting in fatal neonatal lung disease. Acta Paediatr. 2007 Feb;96(2):185-90.</citation>
    <PMID>17429902</PMID>
  </results_reference>
  <results_reference>
    <citation>Garmany TH, Wambach JA, Heins HB, Watkins-Torry JM, Wegner DJ, Bennet K, An P, Land G, Saugstad OD, Henderson H, Nogee LM, Cole FS, Hamvas A. Population and disease-based prevalence of the common mutations associated with surfactant deficiency. Pediatr Res. 2008 Jun;63(6):645-9. doi: 10.1203/PDR.0b013e31816fdbeb.</citation>
    <PMID>18317237</PMID>
  </results_reference>
  <results_reference>
    <citation>McBee AD, Wegner DJ, Carlson CS, Wambach JA, Yang P, Heins HB, Saugstad OD, Trusgnich MA, Watkins-Torry J, Nogee LM, Henderson H, Cole FS, Hamvas A. Recombination as a mechanism for sporadic mutation in the surfactant protein-C gene. Pediatr Pulmonol. 2008 May;43(5):443-50. doi: 10.1002/ppul.20782.</citation>
    <PMID>18383112</PMID>
  </results_reference>
  <results_reference>
    <citation>Hamvas A, Heins HB, Guttentag SH, Wegner DJ, Trusgnich MA, Bennet KW, Yang P, Carlson CS, An P, Cole FS. Developmental and genetic regulation of human surfactant protein B in vivo. Neonatology. 2009;95(2):117-24. doi: 10.1159/000153095. Epub 2008 Sep 6.</citation>
    <PMID>18776725</PMID>
  </results_reference>
  <results_reference>
    <citation>Druley TE, Vallania FL, Wegner DJ, Varley KE, Knowles OL, Bonds JA, Robison SW, Doniger SW, Hamvas A, Cole FS, Fay JC, Mitra RD. Quantification of rare allelic variants from pooled genomic DNA. Nat Methods. 2009 Apr;6(4):263-5. doi: 10.1038/nmeth.1307. Epub 2009 Mar 1.</citation>
    <PMID>19252504</PMID>
  </results_reference>
  <results_reference>
    <citation>Hamvas A, Nogee LM, Wegner DJ, Depass K, Christodoulou J, Bennetts B, McQuade LR, Gray PH, Deterding RR, Carroll TR, Kammesheidt A, Kasch LM, Kulkarni S, Cole FS. Inherited surfactant deficiency caused by uniparental disomy of rare mutations in the surfactant protein-B and ATP binding cassette, subfamily a, member 3 genes. J Pediatr. 2009 Dec;155(6):854-859.e1. doi: 10.1016/j.jpeds.2009.06.006. Epub 2009 Aug 3.</citation>
    <PMID>19647838</PMID>
  </results_reference>
  <results_reference>
    <citation>Tomazela DM, Patterson BW, Hanson E, Spence KL, Kanion TB, Salinger DH, Vicini P, Barret H, Heins HB, Cole FS, Hamvas A, MacCoss MJ. Measurement of human surfactant protein-B turnover in vivo from tracheal aspirates using targeted proteomics. Anal Chem. 2010 Mar 15;82(6):2561-7. doi: 10.1021/ac1001433.</citation>
    <PMID>20178338</PMID>
  </results_reference>
  <results_reference>
    <citation>Wambach JA, Yang P, Wegner DJ, An P, Hackett BP, Cole FS, Hamvas A. Surfactant protein-C promoter variants associated with neonatal respiratory distress syndrome reduce transcription. Pediatr Res. 2010 Sep;68(3):216-20. doi: 10.1203/00006450-201011001-00421.</citation>
    <PMID>20539253</PMID>
  </results_reference>
  <results_reference>
    <citation>Anadkat JS, Kuzniewicz MW, Chaudhari BP, Cole FS, Hamvas A. Increased risk for respiratory distress among white, male, late preterm and term infants. J Perinatol. 2012 Oct;32(10):780-5. doi: 10.1038/jp.2011.191. Epub 2012 Jan 5.</citation>
    <PMID>22222548</PMID>
  </results_reference>
  <results_reference>
    <citation>Agrawal A, Hamvas A, Cole FS, Wambach JA, Wegner D, Coghill C, Harrison K, Nogee LM. An intronic ABCA3 mutation that is responsible for respiratory disease. Pediatr Res. 2012 Jun;71(6):633-7. doi: 10.1038/pr.2012.21. Epub 2012 Feb 15.</citation>
    <PMID>22337229</PMID>
  </results_reference>
  <results_reference>
    <citation>Bereman MS, Tomazela DM, Heins HS, Simonato M, Cogo PE, Hamvas A, Patterson BW, Cole FS, MacCoss MJ. A method to determine the kinetics of multiple proteins in human infants with respiratory distress syndrome. Anal Bioanal Chem. 2012 Jun;403(8):2397-402. doi: 10.1007/s00216-012-5953-3. Epub 2012 Apr 14.</citation>
    <PMID>22526637</PMID>
  </results_reference>
  <results_reference>
    <citation>Wambach JA, Wegner DJ, Depass K, Heins H, Druley TE, Mitra RD, An P, Zhang Q, Nogee LM, Cole FS, Hamvas A. Single ABCA3 mutations increase risk for neonatal respiratory distress syndrome. Pediatrics. 2012 Dec;130(6):e1575-82. doi: 10.1542/peds.2012-0918. Epub 2012 Nov 19.</citation>
    <PMID>23166334</PMID>
  </results_reference>
  <results_reference>
    <citation>Hamvas A, Deterding RR, Wert SE, White FV, Dishop MK, Alfano DN, Halbower AC, Planer B, Stephan MJ, Uchida DA, Williames LD, Rosenfeld JA, Lebel RR, Young LR, Cole FS, Nogee LM. Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1. Chest. 2013 Sep;144(3):794-804. doi: 10.1378/chest.12-2502.</citation>
    <PMID>23430038</PMID>
  </results_reference>
  <results_reference>
    <citation>Sen P, Yang Y, Navarro C, Silva I, Szafranski P, Kolodziejska KE, Dharmadhikari AV, Mostafa H, Kozakewich H, Kearney D, Cahill JB, Whitt M, Bilic M, Margraf L, Charles A, Goldblatt J, Gibson K, Lantz PE, Garvin AJ, Petty J, Kiblawi Z, Zuppan C, McConkie-Rosell A, McDonald MT, Peterson-Carmichael SL, Gaede JT, Shivanna B, Schady D, Friedlich PS, Hays SR, Palafoll IV, Siebers-Renelt U, Bohring A, Finn LS, Siebert JR, Galambos C, Nguyen L, Riley M, Chassaing N, Vigouroux A, Rocha G, Fernandes S, Brumbaugh J, Roberts K, Ho-Ming L, Lo IF, Lam S, Gerychova R, Jezova M, Valaskova I, Fellmann F, Afshar K, Giannoni E, Muhlethaler V, Liang J, Beckmann JS, Lioy J, Deshmukh H, Srinivasan L, Swarr DT, Sloman M, Shaw-Smith C, van Loon RL, Hagman C, Sznajer Y, Barrea C, Galant C, Detaille T, Wambach JA, Cole FS, Hamvas A, Prince LS, Diderich KE, Brooks AS, Verdijk RM, Ravindranathan H, Sugo E, Mowat D, Baker ML, Langston C, Welty S, Stankiewicz P. Novel FOXF1 mutations in sporadic and familial cases of alveolar capillary dysplasia with misaligned pulmonary veins imply a role for its DNA binding domain. Hum Mutat. 2013 Jun;34(6):801-11. doi: 10.1002/humu.22313. Epub 2013 Apr 12.</citation>
    <PMID>23505205</PMID>
  </results_reference>
  <results_reference>
    <citation>Wambach JA, Casey AM, Fishman MP, Wegner DJ, Wert SE, Cole FS, Hamvas A, Nogee LM. Genotype-phenotype correlations for infants and children with ABCA3 deficiency. Am J Respir Crit Care Med. 2014 Jun 15;189(12):1538-43. doi: 10.1164/rccm.201402-0342OC.</citation>
    <PMID>24871971</PMID>
  </results_reference>
  <results_reference>
    <citation>Wambach JA, Wegner DJ, Heins HB, Druley TE, Mitra RD, Hamvas A, Cole FS. Synonymous ABCA3 variants do not increase risk for neonatal respiratory distress syndrome. J Pediatr. 2014 Jun;164(6):1316-21.e3. doi: 10.1016/j.jpeds.2014.02.021. Epub 2014 Mar 20.</citation>
    <PMID>24657120</PMID>
  </results_reference>
  <results_reference>
    <citation>Jackson T, Wegner DJ, White FV, Hamvas A, Cole FS, Wambach JA. Respiratory failure in a term infant with cis and trans mutations in ABCA3. J Perinatol. 2015 Mar;35(3):231-2. doi: 10.1038/jp.2014.236.</citation>
    <PMID>25712598</PMID>
  </results_reference>
  <results_reference>
    <citation>Coghlan MA, Shifren A, Huang HJ, Russell TD, Mitra RD, Zhang Q, Wegner DJ, Cole FS, Hamvas A. Sequencing of idiopathic pulmonary fibrosis-related genes reveals independent single gene associations. BMJ Open Respir Res. 2014 Dec 10;1(1):e000057. doi: 10.1136/bmjresp-2014-000057. eCollection 2014.</citation>
    <PMID>25553246</PMID>
  </results_reference>
  <results_reference>
    <citation>Ramos EI, Bien-Willner GA, Li J, Hughes AE, Giacalone J, Chasnoff S, Kulkarni S, Parmacek M, Cole FS, Druley TE. Genetic variation in MKL2 and decreased downstream PCTAIRE1 expression in extreme, fatal primary human microcephaly. Clin Genet. 2014 May;85(5):423-32. doi: 10.1111/cge.12197. Epub 2013 Jun 18.</citation>
    <PMID>23692340</PMID>
  </results_reference>
  <results_reference>
    <citation>van Meel E, Wegner DJ, Cliften P, Willing MC, White FV, Kornfeld S, Cole FS. Rare recessive loss-of-function methionyl-tRNA synthetase mutations presenting as a multi-organ phenotype. BMC Med Genet. 2013 Oct 8;14:106. doi: 10.1186/1471-2350-14-106.</citation>
    <PMID>24103465</PMID>
  </results_reference>
  <results_reference>
    <citation>Szafranski P, Dharmadhikari AV, Wambach JA, Towe CT, White FV, Grady RM, Eghtesady P, Cole FS, Deutsch G, Sen P, Stankiewicz P. Two deletions overlapping a distant FOXF1 enhancer unravel the role of lncRNA LINC01081 in etiology of alveolar capillary dysplasia with misalignment of pulmonary veins. Am J Med Genet A. 2014 Aug;164A(8):2013-9. doi: 10.1002/ajmg.a.36606. Epub 2014 May 19.</citation>
    <PMID>24842713</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen YJ, Wambach JA, DePass K, Wegner DJ, Chen SK, Zhang QY, Heins H, Cole FS, Hamvas A. Population-based frequency of surfactant dysfunction mutations in a native Chinese cohort. World J Pediatr. 2016 May;12(2):190-5. doi: 10.1007/s12519-015-0047-x. Epub 2015 Nov 7.</citation>
    <PMID>26547207</PMID>
  </results_reference>
  <results_reference>
    <citation>Shen CL, Zhang Q, Meyer Hudson J, Cole FS, Wambach JA. Genetic Factors Contribute to Risk for Neonatal Respiratory Distress Syndrome among Moderately Preterm, Late Preterm, and Term Infants. J Pediatr. 2016 May;172:69-74.e2. doi: 10.1016/j.jpeds.2016.01.031. Epub 2016 Feb 28.</citation>
    <PMID>26935785</PMID>
  </results_reference>
  <results_reference>
    <citation>Wambach JA, Yang P, Wegner DJ, Heins HB, Kaliberova LN, Kaliberov SA, Curiel DT, White FV, Hamvas A, Hackett BP, Cole FS. Functional Characterization of ATP-Binding Cassette Transporter A3 Mutations from Infants with Respiratory Distress Syndrome. Am J Respir Cell Mol Biol. 2016 Nov;55(5):716-721.</citation>
    <PMID>27374344</PMID>
  </results_reference>
  <results_reference>
    <citation>Eldridge WB, Zhang Q, Faro A, Sweet SC, Eghtesady P, Hamvas A, Cole FS, Wambach JA. Outcomes of Lung Transplantation for Infants and Children with Genetic Disorders of Surfactant Metabolism. J Pediatr. 2017 May;184:157-164.e2. doi: 10.1016/j.jpeds.2017.01.017. Epub 2017 Feb 16.</citation>
    <PMID>28215425</PMID>
  </results_reference>
  <results_reference>
    <citation>Stout MJ, Demaree D, Merfeld E, Tuuli MG, Wambach JA, Cole FS, Cahill AG. Neonatal Outcomes Differ after Spontaneous and Indicated Preterm Birth. Am J Perinatol. 2018 Apr;35(5):494-502. doi: 10.1055/s-0037-1608804. Epub 2017 Nov 28.</citation>
    <PMID>29183099</PMID>
  </results_reference>
  <results_reference>
    <citation>Towe CT, White FV, Grady RM, Sweet SC, Eghtesady P, Wegner DJ, Sen P, Szafranski P, Stankiewicz P, Hamvas A, Cole FS, Wambach JA. Infants with Atypical Presentations of Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins Who Underwent Bilateral Lung Transplantation. J Pediatr. 2018 Mar;194:158-164.e1. doi: 10.1016/j.jpeds.2017.10.026. Epub 2017 Dec 1.</citation>
    <PMID>29198536</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen YJ, Meyer J, Wambach JA, DePass K, Wegner DJ, Fan X, Zhang QY, Hillary H, Cole FS, Hamvas A. Gene variants of the phosphatidylcholine synthesis pathway do not contribute to RDS in the Chinese population. World J Pediatr. 2018 Feb;14(1):52-56. doi: 10.1007/s12519-017-0109-3. Epub 2018 Feb 6.</citation>
    <PMID>29411327</PMID>
  </results_reference>
  <results_reference>
    <citation>Attarian SJ, Leibel SL, Yang P, Alfano DN, Hackett BP, Cole FS, Hamvas A. Mutations in the thyroid transcription factor gene NKX2-1 result in decreased expression of SFTPB and SFTPC. Pediatr Res. 2018 Apr 11. doi: 10.1038/pr.2018.30. [Epub ahead of print]</citation>
    <PMID>29538355</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 11, 2001</study_first_submitted>
  <study_first_submitted_qc>April 11, 2001</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2001</study_first_posted>
  <last_update_submitted>April 30, 2018</last_update_submitted>
  <last_update_submitted_qc>April 30, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Washington University School of Medicine</investigator_affiliation>
    <investigator_full_name>F. Sessions Cole, MD</investigator_full_name>
    <investigator_title>Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Pulmonary surfactant</keyword>
  <keyword>Surfactant protein B</keyword>
  <keyword>Surfactant protein C</keyword>
  <keyword>ABCA3</keyword>
  <keyword>NKX2-1</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Pulmonary Alveolar Proteinosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Surfactants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

